Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextromethorphan as Add-On to Risperidone in Schizophrenia
NCT01189006Phase 3Completed
- Sponsor
- National Cheng Kung University Hospital
- Start
- Jan 2005
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia comparing Dextromethorphan + Risperidone with Placebo + Risperidone (2 arms). Primary endpoint: Positive and Negative Syndrome Scale at 11 weeks. Started Jan 2005; status: completed.
02
Drugs
dextromethorphan
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01189006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01189006.